Investors of Dentsply Sirona Inc. Can Pursue Fraud Claims and Seek Compensation

A Call to Action for Dentsply Sirona Investors

In a notable legal development, the Rosen Law Firm, recognized globally for advocating investor rights, is notifying shareholders of Dentsply Sirona Inc. (NASDAQ: XRAY) about a critical class action lawsuit concerning securities fraud. Investors who held shares of the company between May 6, 2021, and November 6, 2024, are urged to consider their eligibility to join this action by the looming deadline of January 27, 2025.

What This Means for Investors

If you purchased Dentsply Sirona common stock during the specified period, there is a potential opportunity for compensation without any out-of-pocket costs. The firm has arranged a contingency fee model, meaning you only pay if there’s a favorable outcome in your case.

Taking steps to join this class action is essential. You can do this through the official Rosen Law Firm website or by reaching out directly via phone or email for further assistance. A class action lawsuit has already been initiated, and interested parties must file to serve as lead plaintiff, representing their peers in the legal proceedings.

Why Choose Rosen Law Firm?

Rosen Law Firm has established a reputation for loyalty to investor rights, showcasing success in numerous securities class actions. As strong advocates within the legal realm, their team emphasizes the importance of selecting counsel that possesses a verifiable record of achievement. Some law firms merely act as intermediaries, lacking the resources and expertise necessary to efficiently litigate these cases.

Rosen Law Firm achieved significant milestones in the past, including the highest-ever securities settlement against a Chinese company and ranking first in the number of settlements for securities class actions in 2017. Their team has been credited with recovering hundreds of millions of dollars for investors over the years, demonstrating their commitment to investor rights.

Allegations Against Dentsply Sirona

The class action lawsuit alleges that during the specified class period, Dentsply Sirona issued misleading statements or failed to disclose crucial information. Reports indicate that Byte aligners, a product offered by the company, were linked to severe patient injuries, a fact that Dentsply Sirona reportedly concealed through backlogged reports to the Food and Drug Administration (FDA) throughout 2024.

Moreover, the firm is accused of encouraging its customer service representatives and dental professionals to enroll patients who were not suitable candidates for treatment due to other existing dental issues. This marketing strategy created a false narrative about customer satisfaction, skewing the public perception of the company's practices and their patient care.

When these allegations surfaced, the lawsuit maintains that investors suffered financial losses as the truth about Dentsply Sirona's business practices became apparent.

If you are a Dentsply Sirona investor, you have the right to consider joining this class action and potentially recovering some losses incurred during the challenging times represented in the lawsuit. To be informed about updates or further developments, follow the Rosen Law Firm’s updates on social media.

Conclusion

Investors should not overlook the significance of the January 27, 2025 deadline. Acting quickly will ensure that your rights are protected and that you have the opportunity to participate in a potential recovery. For more information or to take action, visit Rosen Law Firm or contact Phillip Kim at 866-767-3653.

Stay connected to legal updates as more information continues to emerge regarding Dentsply Sirona and the class action suit. Remember, your investment may depend on your response to this situation.